Study Tests Targeted Drugs for Multiple Myeloma.
The MyDRUG trial, recently launched by the Multiple Myeloma Research Foundation, aims to apply personalized medicine to multiple myeloma. Patients enrolled in the umbrella trial will have their tumors sequenced and then be matched to targeted therapies based on their mutational profile.